S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
NASDAQ:FLGT

Fulgent Genetics - FLGT Earnings Date, Estimates & Call Transcripts

$34.76
+1.47 (+4.42%)
(As of 01/27/2023 08:54 PM ET)
Add
Compare
Today's Range
$33.15
$35.13
50-Day Range
$29.23
$37.07
52-Week Range
$28.53
$73.47
Volume
171,300 shs
Average Volume
211,911 shs
Market Capitalization
$1.02 billion
P/E Ratio
4.00
Dividend Yield
N/A
Price Target
$45.00

Earnings Summary

Upcoming
Earnings Date
Feb. 22Estimated
Actual EPS
(Nov. 7)
$0.11 Beat By $0.13
Consensus EPS
(Nov. 7)
-$0.02
Last Year's Q4 EPS
(11/9/2021)
$3.93
Skip Charts & View Estimated and Actual Earnings Data

FLGT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FLGT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Fulgent Genetics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20232$0.71$1.13$0.92 
Q2 20232$0.53$0.60$0.57 
Q3 20232$0.46$0.54$0.50 
Q4 20232$0.46$0.58$0.52 
FY 20238$2.16$2.85 $2.51

FLGT Earnings Date and Information

Fulgent Genetics last announced its earnings results on November 7th, 2022. The reported $0.11 earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.13. The firm had revenue of $105.66 million for the quarter, compared to the consensus estimate of $103.70 million. Fulgent Genetics has generated $8.70 earnings per share over the last year ($8.70 diluted earnings per share) and currently has a price-to-earnings ratio of 4.0. Earnings for Fulgent Genetics are expected to decrease in the coming year, from $4.93 to ($3.11) per share. Fulgent Genetics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 22nd, 2023 based off prior year's report dates.

Fulgent Genetics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/22/2023
(Estimated)
        
11/7/2022Q3 2022($0.02)$0.11+$0.13$0.16$103.70 million$105.66 million    
8/4/2022Q2 2022$0.59$0.59$0.81$122.70 million$125.30 million    
5/3/2022Q1 2022$4.32$4.93+$0.61$4.93$300.50 million$320.30 million    
2/23/2022Q4 2021$2.66$3.34+$0.68$3.34$191.10 million$251.67 million    
11/9/2021Q3 2021$1.30$3.93+$2.63$3.93$264.00 million$227.87 million
8/9/20216/30/2021$2.54$2.47($0.07)$2.35$197.34 million$153.60 million    
5/6/20213/31/2021$5.95$6.59+$0.64$6.50$326.46 million$359.43 million  
3/3/202112/31/2020$4.36$6.20+$1.84$6.08$199.38 million$294.98 million  
11/9/2020Q3$0.39$2.08+$1.69$1.92$51.73 million$101.72 million  
8/4/20206/30/2020$0.01$0.17+$0.16$0.20$14.52 million$17.27 million  
5/4/20203/31/2020$0.02($0.03)($0.05)($0.07)$7.69 million$7.75 million  
3/10/202012/31/2019$0.04$0.04$0.01$9.02 million$8.39 million  
11/4/2019Q3 2019$0.01$0.09+$0.08$0.10$8.48 million$10.35 million
8/5/2019Q2 2019($0.04)$0.02+$0.06$0.02$6.42 million$8.42 million  
5/7/20193/31/2019($0.06)($0.09)($0.03)($0.08)$5.46 million$5.37 million  
2/28/2019Q4 2018($0.01)($0.03)($0.02)($0.01)$5.90 million$5.68 million
11/6/2018Q3 2018($0.03)($0.03)($0.03)$5.63 million
8/6/2018Q2 2018($0.03)($0.01)+$0.02($0.02)$4.97 million$5.40 million
5/7/2018Q1 2018($0.04)($0.06)($0.02)($0.05)$4.65 million
2/28/2018Q4 2017($0.03)($0.09)($0.06)($0.08)$5.26 million$4.28 million
11/6/2017Q3 2017($0.05)($0.05)($0.04)$5.52 million$4.50 million
8/7/2017Q2 2017$0.0160$0.02+$0.0040$5.03 million$4.64 million  
5/8/2017Q1 2017$0.03$0.02($0.01)$0.03$5.85 million$5.31 million  
2/27/2017Q416$0.04$0.05+$0.01$0.05$5.99 million$5.85 million  
11/14/2016Q3 2016$0.08($0.44)($0.52)($0.44)$5.16 million$5.01 million












Fulgent Genetics Earnings - Frequently Asked Questions

When is Fulgent Genetics's earnings date?

Fulgent Genetics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 22nd, 2023 based off last year's report dates. Learn more on FLGT's earnings history.

Did Fulgent Genetics beat their earnings estimates last quarter?

In the previous quarter, Fulgent Genetics (NASDAQ:FLGT) reported $0.11 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.02) by $0.13. Learn more on analysts' earnings estimate vs. FLGT's actual earnings.

How can I listen to Fulgent Genetics's earnings conference call?

The conference call for Fulgent Genetics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Fulgent Genetics's conference call transcript?

The conference call transcript for Fulgent Genetics's latest earnings report can be read online. Read Transcript

How much revenue does Fulgent Genetics generate each year?

Fulgent Genetics (NASDAQ:FLGT) has a recorded annual revenue of $992.58 million.

How much profit does Fulgent Genetics generate each year?

Fulgent Genetics (NASDAQ:FLGT) has a recorded net income of $507.36 million. FLGT has generated $8.70 earnings per share over the last four quarters.

What is Fulgent Genetics's price-to-earnings ratio?

Fulgent Genetics (NASDAQ:FLGT) has a trailing price-to-earnings ratio of 4.00 and a forward price-to-earnings ratio of 7.05.

What is Fulgent Genetics's EPS forecast for next year?

Fulgent Genetics's earnings are expected to decrease from $4.93 per share to ($3.11) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:FLGT) was last updated on 1/30/2023 by MarketBeat.com Staff